American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Here’s why I’d sell SCHD and JEPI ETFs and buy UTF instead

by admin April 22, 2025
April 22, 2025
Here’s why I’d sell SCHD and JEPI ETFs and buy UTF instead

Income-focused exchange-traded funds have retreated this year, mirroring the performance of mainstream Wall Street indices like the Nasdaq 100 and S&P 500. 

The popular Schwab US Dividend Equity ETF (SCHD) has dropped by over 12% from its highest point this year. It has also formed a death cross pattern, pointing to further declines in the near term. 

Similarly, the JPMorgan Equity Premium Income ETF (JEPI) has dropped to $ 52.70, down 10.6% from its highest level this year. It has dropped, as have most companies in the S&P 500 index, especially those in the tech industry. 

This article explores why the Cohen & Steers Infrastructure Fund (UTF) closed-end fund is a better investment at the current conditions.

Cohen & Steers Infrastructure Fund is less exposed to tariffs and tech

The first reason why I’d consider investing in the CEF fund in these market conditions is that its portfolio companies have no exposure to tariffs and technology stocks.

Instead, it is comprised of companies in the utility industry, which are not exposed to tariffs. Additionally, customers will continue to pay their water and electricity bills, regardless of whether there is a recession or not. Also, these companies have not been tariffed.

The top companies in the UTF fund are NiSource, a gas distribution company, NextEra Energy, Duke Energy, TC Energy, American Tower, National Grid, Southern Company, and Dominion Resources. 

NextEra and Duke Energy are large utility companies that supply energy to millions of customers in the United States. American Tower is a REIT that offers cell towers to all companies in the telecommunications industry. 

These companies are also not exposed to the artificial intelligence industry, which is showing signs of slowing down. 

UTF Fund is beating the SCHD and JEPI funds

UTF vs SCHD vs JEPI

Furthermore, the Cohen & Steers Infrastructure Fund is outperforming the SCHD and JEPI ETFs. Its total return this year is 4.35%, higher than SCHD’s minus 7.5% and JEPI’s minus 6.70%. 

The same performance has happened in the last twelve months as the UTF fund has had a total return of 18%. SCHD has remained unchanged during this period, while JEPI has increased by 1.56%. 

This means that an investment in UTF would have generated a higher return than the two popular dividend funds. UTF’s total returns in the last 3 years was 6.48%, while SCHD rose by 5.38%. JEPI has jumped by 11.3% in this period. 

UTF trades at a discount 

Further, like other closed-end funds, Cohen & Steers Infrastructure Fund trades at a discount to its net asset value (NAV). Its NAV stands at $26.22, while its market price is $24.4. This results to a discount of 6.76%. 

Its discount has widened due to the ongoing market volatility. This means that investors buying the UTF fund are paying a discount, giving them a margin of safety. In contrast, the SCHD ETF has a discount to NAV of 0.12%, while JEPI has 0,09%.

UTF Fund has better technicals

UTF stock by TradingView

The SCHD ETF has formed a death cross, indicating that it may continue to decline in the near term. JEPI may also exhibit this pattern due to its exposure to technology companies. 

Read more: Red alert: SCHD ETF just flashed a rare risky pattern

UTF, on the other hand, has rebounded from its year-to-date low of $22 to $24.5. It has moved above the 100-day and 50-day Exponential Moving Averages (EMA), a sign that bulls are in control.

Therefore, the fund is likely to continue rising as bulls target the year-to-date high of $25.75, which is 5.3% above the current level. 

The post Here’s why I’d sell SCHD and JEPI ETFs and buy UTF instead appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
European stocks slide as trade fears, Trump’s Fed criticism dampen post-holiday mood
next post
Pharma giant Roche pledges $50 billion US investment in R&D, manufacturing

Related Posts

Asian markets close: Hong Kong leads gains, Nikkei...

June 3, 2025

Ivan Boesky, inspiration for ‘Wall Street’ villain Gordon...

May 22, 2024

Five ETFs to invest in to hedge against...

February 9, 2025

Wayfair to open its first large store, as...

May 19, 2024

Lloyds share price outlook ahead of earnings: buy,...

April 24, 2025

Long AMCR: Amcor Plc Surges Past $10 Mark...

February 5, 2025

TOP Financial and AMTD Digital stocks surged: time...

October 3, 2024

Dow slips for first losing day in nine...

May 16, 2024

3 reasons why the S&P 500 ETFs like...

March 4, 2025

PepeX records $1 million in presale as Trump-backed...

March 30, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Kraft Heinz plans breakup, weighs $20 billion grocery spin-off: report

      July 13, 2025
    • Trump’s 50% tariff on Brazil imports to brew trouble for Starbucks and Dutch Bros

      July 13, 2025
    • US to announce 30% tariff on EU and Mexico says Trump

      July 13, 2025
    • Why India is rushing to build bigger banks and what’s standing in the way

      July 13, 2025
    • Wall Street braces for weakest earnings season since 2023 amid market highs

      July 13, 2025

    Categories

    • Business (3,358)
    • Investing (2,607)
    • Latest News (2,017)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved